Association between genetic ancestry and all-cause mortality among Black and White ever-smokers in the PLCO cohortCANCER RESEARCHIF16.62023-04-040PRE
Association of genetic ancestry with lung-cancer risk in White and Black ever-smokersCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42023-01-010PRE
Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune MicroenvironmentSCIENTIFIC REPORTSIF3.92019-10-1824OAAI
Multivariate exome analysis identifies CXCR5-CXCL13 signaling as a key driver in early breast cancer development and prognosisCANCER RESEARCHIF16.62019-07-010PRE
CXCR5-CXCL13 signaling contributes to CLL relapse and patient survivalCANCER RESEARCHIF16.62019-07-010PRE
A multi-variate transcriptome analysis of CXCR5-CXCL13 signaling in ovarian cancerCANCER RESEARCHIF16.62019-07-010PRE
The role of CXCL13, its sole receptor CXCR5, and associated genes in multiple myeloma progressionCANCER RESEARCHIF16.62019-07-010PRE
Novel adjuvant therapy for obesity-related cancersCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42017-02-050PRE
IONP-LPrA2 and PEG-LPrA2 therapies for triple negative breast cancerCANCER RESEARCHIF16.62016-07-150PRE
PEG-LPrA2 is a non-toxic adjuvant for triple negative breast cancerCANCER RESEARCHIF16.62016-07-150PRE
Targeting the obesity/leptin link to TNBC: A breast cancer disparity problemCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42016-03-011PRE
Tackling obesity-related cancer health disparity, new inhibitors of leptin signalingCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42016-03-010PRE
Leptin peptide receptor antagonist linked to nanoparticles: A novel adjuvant therapy for triple negative breast cancerCANCER RESEARCHIF16.62015-05-010PRE